Eurican L4

Authorised

This medicine is authorised for use in the European Union

inactivated immunological veterinary medicinal product containing Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 16070, L. interrogans, serogroup icterohaemorrhagiae, serovar icterohaemorrhagiae, strain 16069, L. interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, strain Grippo Mal 1540, L. interrogans, serogroup Australis, serovar Bratislava, strain

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website.

Product details

• Name of medicine:
  Eurican L4
• Active substance:
  inactivated immunological veterinary medicinal product containing Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 16070, L. interrogans, serogroup icterohaemorrhagiae, serovar icterohaemorrhagiae, strain 16069, L. interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, strain Grippo Mal 1540, L. interrogans, serogroup Australis, serovar Bratislava, strain
• International non-proprietary name (INN) or common name:
  inactivated immunological veterinary medicinal product containing Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 16070, L. interrogans, serogroup icterohaemorrhagiae, serovar icterohaemorrhagiae, strain 16069, L. interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, strain Grippo Mal 1540, L. interrogans, serogroup Australis, serovar Bratislava, strain

Pharmacotherapeutic group

• Immunologicals for canidae
• Inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia)
• leptospira

Authorisation details

• EMA product number:
  EMEA/V/C/005944

Assessment history

Initial marketing authorisation documents

CVMP summary of positive opinion for Eurican L4

AdoptedReference Number: EMA/CVMP/54218/2023